Reynders Mc Veigh Capital Management, LLC Moderna, Inc. Transaction History
Reynders Mc Veigh Capital Management, LLC
- $1.89 Billion
- Q3 2024
A detailed history of Reynders Mc Veigh Capital Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Reynders Mc Veigh Capital Management, LLC holds 8,903 shares of MRNA stock, worth $350,956. This represents 0.03% of its overall portfolio holdings.
Number of Shares
8,903
Previous 13,670
34.87%
Holding current value
$350,956
Previous $1.62 Million
63.34%
% of portfolio
0.03%
Previous 0.09%
Shares
12 transactions
Others Institutions Holding MRNA
# of Institutions
913Shares Held
236MCall Options Held
10.6MPut Options Held
18.7M-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.59 Billion0.05% of portfolio
-
Baillie Gifford & CO38.9MShares$1.53 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.01 Billion0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$664 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$285 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $15.4B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...